Mariner, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Mariner, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$0.28 - $1.16 $796 - $3,297	2,843 Added 0.14%	2,103,390 $694,000
Q1 2024 May 15, 2024	BUY	$1.06 - $1.67 $10,818 - $17,044	10,206 Added 0.49%	2,100,547 $2.44 Million
Q4 2023 Feb 14, 2024	BUY	$1.26 - $1.79 $16,773 - $23,828	13,312 Added 0.64%	2,090,341 $3.53 Million
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $65,905 - $103,974	40,935 Added 2.01%	2,077,029 $3.76 Million
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $2.3 Million - $3.93 Million	2,016,434 Added 10256.53%	2,036,094 $3.79 Million
Q1 2023 May 12, 2023	SELL	$1.2 - $2.19 $26,102 - $47,636	-21,752 Reduced 52.53%	19,660 $26,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $28,924 - $62,462	17,745 Added 74.98%	41,412 $70,000
Q3 2022 Nov 10, 2022	BUY	$0.73 - $3.74 $17,276 - $88,514	23,667 New	23,667 $74,000

48.4M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $9.25B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.